PAVmed Inc. (PAVM)
NASDAQ: PAVM · IEX Real-Time Price · USD
1.010
-0.030 (-2.88%)
At close: Jul 19, 2024, 4:00 PM
1.080
+0.070 (6.93%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

PAVmed Revenue

PAVmed had revenue of $3.02M in the twelve months ending March 31, 2024, with 375.71% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.01M with 126.46% year-over-year growth. In the year 2023, PAVmed had annual revenue of $2.45M with 550.40% growth.

Revenue (ttm)
$3.02M
Revenue Growth
+375.71%
P/S Ratio
3.16
Revenue / Employee
$28,187
Employees
107
Market Cap
9.53M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.45M2.08M550.40%
Dec 31, 2022377.00K-123.00K-24.60%
Dec 31, 2021500.00K--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pieris Pharmaceuticals 40.93M
Plus Therapeutics 6.08M
Elevai Labs 2.18M
Mangoceuticals 844.87K
Nexalin Technology 158.86K
Silo Pharma 72.10K
ABVC BioPharma 25.36K
Revenue Rankings